Responses of Spermatogenous Tissue and Mechanisms of Their Development Upon Cytostatic Exposure

A M Dygai1, A V Chaikovskii2, V V Zhdanov1

  • 1E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia.

Insights

Single paclitaxel administration reduced sperm cell count and spermatogonium population in testicular tissue. This damage stemmed from a depleted precursor pool and impaired microenvironment, hindering tissue regeneration.

Area of Science:

  • Reproductive biology
  • Toxicology
  • Cell biology

Background:

  • Paclitaxel is a chemotherapy drug with known cytotoxic effects.
  • Spermatogenesis is a complex process highly sensitive to external agents.
  • The testicular microenvironment plays a crucial role in maintaining germ cell function.

Purpose of the Study:

  • To investigate the effects of paclitaxel on testicular tissue and spermatogenesis.
  • To elucidate the mechanisms underlying paclitaxel-induced testicular damage.
  • To assess the impact on germ cell precursors and the tissue microenvironment.

Main Methods:

  • Administration of a single dose of paclitaxel to male subjects.
  • Histological examination of testicular tissue.
  • Evaluation of spermatogonium population and sperm cell counts.

Main Results:

  • A significant decrease in total sperm cell number was observed.
  • Reduction in the spermatogonium population indicated damage to germline stem cells.
  • Paclitaxel-induced damage was linked to the depletion of the precursor cell pool and suppressed microenvironment secretory function.

Conclusions:

  • Paclitaxel exerts cytotoxic effects on testicular tissue, impairing spermatogenesis.
  • The regenerative potential of testicular tissue is compromised by paclitaxel, primarily through precursor pool depletion.
  • Alterations in the testicular microenvironment's secretory function contribute to paclitaxel-induced germ cell damage.